Makita S, Ota S, Mishima Y, Usuki K, et al. Japanese phase Ib study of the oral PI3K-delta and -gamma inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. Int J Hematol 2023 Dec 27. doi: 10.1007/s12185-023-03689.
PMID: 38150138